L
Luiz Vicente Rizzo
Researcher at Albert Einstein Hospital
Publications - 53
Citations - 3818
Luiz Vicente Rizzo is an academic researcher from Albert Einstein Hospital. The author has contributed to research in topics: Cytokine & Autoimmunity. The author has an hindex of 25, co-authored 51 publications receiving 3251 citations. Previous affiliations of Luiz Vicente Rizzo include University of São Paulo & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
Patrícia O. Guimarães,Daniel Quirk,Remo H. Furtado,Lilia N. Maia,José F. Saraiva,Murillo Oliveira Antunes,Roberto Kalil Filho,Vagner Madrini Junior,Alexandre de Matos Soeiro,Alexandre P. Tognon,Viviane C Veiga,Priscilla de Aquino Martins,Diogo D.F. Moia,Bruna S. Sampaio,Silvia R.L. Assis,Ronaldo V P Soares,Luciana P.A. Piano,Kleber Castilho,Roberta G.R.A.P. Momesso,Frederico Monfardini,Hélio Penna Guimarães,Dario Ponce de Leon,Majori Dulcine,Marcia Pinheiro,Levent M. Gunay,J. Jasper Deuring,Luiz Vicente Rizzo,Tamas Koncz,Otavio Berwanger +28 more
TL;DR: Among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or respiratory failure through day 28 than placebo, and the proportional odds of having a worse score on the eight-level ordinal scale with tofacinib, as compared with placebo.
Journal ArticleDOI
Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil
Asis Khan,Craig T. Jordan,Cristina Muccioli,Adriana L. Vallochi,Luiz Vicente Rizzo,Rubens Belfort,Ricardo Wagner de Almeida Vitor,Claudio Silveira,L. David Sibley +8 more
TL;DR: Brazilian strains of T. gondii differ from lineages in North America and Europe; these differences may underlie severe ocular disease.
Journal ArticleDOI
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial
Robert B. Nussenblatt,Eric Fortin,Rhett M. Schiffman,Luiz Vicente Rizzo,Janine A. Smith,Paul Van Veldhuisen,Pushpa Sran,Anita Yaffe,Carolyn K. Goldman,Thomas A. Waldmann,Scott M. Whitcup +10 more
TL;DR: It is suggested that anti-IL-2 receptor therapy may be an effective therapeutic approach for uveitis and, by implication, other disorders with a predominant Th1 profile.
Journal ArticleDOI
Endometriosis: an inflammatory disease with a Th2 immune response component
Sergio Podgaec,Mauricio Simões Abrão,João Antonio Dias,Luiz Vicente Rizzo,R. de Oliveira,Edmund Chada Baracat +5 more
TL;DR: Endometriosis is an inflammatory disease involving a possible shift towards Th1 and Th2 immune response component, as demonstrated by the relative increase in cytokines characteristic of this pattern of immune response.
Journal ArticleDOI
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses.
Marta A. Toscano,Alessandra Gonçalves Commodaro,Juan M. Ilarregui,Germán A Bianco,Ana C. Liberman,Horacio M. Serra,Jun Hirabayashi,Luiz Vicente Rizzo,Gabriel A. Rabinovich +8 more
TL;DR: The ability of Gal-1 to counteract Th1-mediated responses through different, but potentially overlapping anti-inflammatory mechanisms is underscored and a possible therapeutic use of this protein is suggested for the treatment of human uveitic diseases of autoimmune etiology.